FontsA A
ContrastA A
Newsletter sign-up
I give permission for BBMRI-ERIC to send me their newsletter and emails about subjects which they think may be of interest to me. I can unsubscribe from all emails at any time. I understand that my information will be processed according to BBMRI-ERIC's privacy notice.

ISIDORe

ISIDORe – Integrated Services for Infectious Disease Outbreak Research

Topic: HORIZON-INFRA-2021-EMERGENCY-02 Research infrastructure services for rapid research responses to COVID-19 and other infectious disease epidemics

Duration: 36 months

Start date: 1 February 2022

Grant agreement: 101046133

Web: https://isidore-project.eu/

Total request Grant by Consortium: €20,998,624

Total request Grant by BBMRI-ERIC: €602,208

 

Benefit/tasks for BBMRI-ERIC: BBMRI-ERIC will be contributing to Work Package 4 on Quality for data, ELSI, training and customer satisfaction measures as well as Work Package 8 on Provision of access to clinical samples. BBMRI’s affiliated entities in WP4 are Leipzig Medical Biobank (LMB), Institut für Klinische Chemie und Laboratoriums-diagnostik Jena (IBBJ) and UKCRC Tissue Directory and Coordination Centre, UCL. In addition, 40 BBMRI-ERIC member biobanks will be acting as service providers for WP8.  

Abstract

The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest and most diverse research and service providing instrument to study infectious diseases in Europe, from structural biology to clinical trials. Giving scientists access to the whole extent of our state of the art facilities, cutting edge services, advanced equipment and expertise, in an integrated way and with a common goal, will enable or accelerate the generation of new knowledge and intervention tools to ultimately help control SARS-CoV-2 in particular, and epidemic prone pathogens in general, while avoiding fragmentation and duplication among European initiatives.

Such a global and interdisciplinary approach is meant to allow the implementation of user projects that are larger, more ambitious and more impactful than the EU supported transnational activities that the consortium is used to run. Our proposition is ambitious but achievable in a timely fashion due to the relevance and previous experience of the partners that we have gathered and that have complementary fields of expertise, which addresses the need for an interdisciplinary effort. Leveraging all these existing strengths to develop synergies will create an additional value and enhance Europe capacity for controlling emerging or re emerging and epidemic infectious diseases, starting with the COVID-19 pandemic. Such a global and coordinated approach is consistent with the recommendations of the One Health concept and necessary to make significant contributions to solving complex societal problems like epidemics and pandemics.


The website was co-funded within ADOPT BBMRI-ERIC, a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 676550.
We use cookies to analyse the traffic on our websites. All personal data is anonymized and not shared with third parties! Click here for more information.
Accept